Stacy Saravo, like anyone who’s been given a terrible diagnosis, has received her share of well-meaning but dumb advice. (“Eat lemons! They’ll cure cancer.”) But there’s one moment that takes the cake. She was undergoing chemotherapy, feeling uncomfortable, had no eyebrows, and her immune system was low … yet she decided to go to the … Continued
Dr. Ron Buckanovich, an OCRA grantee, uses a metaphor to describe his work. “If I’m trying to get into Chicago and the highways that get me into the city are blocked off, no matter how important my job is, I’m not going to get there.” He’s talking about immunotherapy and the fact that the cells … Continued
Jamie Davey is an open book. She will tell you about her ‘buns and guns’ class at the gym, how you can best support friends and loved ones facing ovarian cancer, and what it’s like being a 28-year-old in menopause. Jamie lives in Trumbull County, Ohio and was 26 years old when she was diagnosed. … Continued
What do the fur patterns of tigers have to do with advances in ovarian cancer treatment? Juan Cubillos-Ruiz, PhD, an OCRA grantee, grew up on a farm near Bogota, Colombia. He spent his younger years looking at the world around him, questioning everything. Why was corn white, yellow or purple? Why did foods vary in … Continued
“Be present and embrace the suck.” This is Andrew Simone’s personal mantra. It’s what got him through a nearly 2000-mile, 47-day bike ride from Vancouver, British Columbia to Tijuana, Mexico in 2018. And a “short loop” (500 miles) around the Olympic National Forest in Washington State in 2019. It’s what will get him through a … Continued
Are you an ovarian cancer survivor, patient, or caregiver? Don’t miss YOUR chance to learn what’s new in ovarian cancer treatments and research, and to meet others in the ovarian cancer community. Early Bird Registration is open! OCRA’s Ovarian Cancer National Conference® brings together people from across the country for a weekend of informative presentations, … Continued
(February 13, 2020) PARP inhibitors have shown to be a promising treatment option for a subset of ovarian cancer patients. As of February 2020, there are currently 3 FDA-approved PARP inhibitors for ovarian cancer: olaparib (Lynparza), niraparib (Zejula), and rucaparib (Rubraca). In an interview with OncLive, Dr. Robert Coleman, a member of OCRA’s Scientific Advisory … Continued
OCRA is pleased to announce we have earned our tenth consecutive 4-star rating from Charity Navigator, America’s largest independent charity evaluator. We’re proud to again receive this rating, because it reflects our deep commitment to finding a cure for ovarian cancer, investing heavily in discovering new treatments, and hastening breakthroughs to fight this disease. A … Continued
(January 15, 2020) A new study in the Journal of the American Medical Association (JAMA) found no statistically significant association between self-reported use of powder in the genital area and subsequent risk of developing ovarian cancer. Published earlier this month, the study used a pooled analysis of 4 large US cohorts, including 252,745 women with … Continued
(January 13, 2020) Thanks to your support, 22 top scientists at 19 eminent medical centers across the world will delve into important topics across the ovarian cancer landscape. In 2020, along with our other ongoing grants and programs, OCRA is investing nearly $9 million in the fight against ovarian cancer. These grants, awarded internationally for … Continued
(January 6, 2020) For the past 14 years, OCRA has hosted Turn Up the Heat: Celebrating Female Superstars, a fabulous foodie fest packed full of tantalizing treats and eats from the most exciting female chefs, mixologists and restaurateurs, all for a good cause. And it is with profound gratitude for the opportunity to host this … Continued
(December 23, 2019) OCRA-funded scientist Dr. Sarah Gitto is making strides toward better harnessing the immune system to fight ovarian cancer. As reported recently in Gynecologic Oncology, Dr. Gitto and her colleagues at the University of Pennsylvania successfully created patient “avatars,” which mimic a patient’s biological profile based on a number of factors. Using these … Continued
Get email updates about research news, action alerts, and ways to join the fight.
